ALMDT Fundamental Analysis - MEDIAN TECHNOLOGIES

Fundamental Rating

Taking everything into account, ALMDT scores 2 out of 10 in our fundamental rating. ALMDT was compared to 11 industry peers in the Health Care Technology industry. ALMDT has a bad profitability rating. Also its financial health evaluation is rather negative. ALMDT is valied quite expensively at the moment, while it does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

ALMDT had negative earnings in the past year.

In the past year ALMDT has reported a negative cash flow from operations.

ALMDT had negative earnings in each of the past 5 years.

In the past 5 years ALMDT always reported negative operating cash flow.

1.2 Ratios

ALMDT has a worse Return On Assets (-111.05%) than 81.82% of its industry peers.

		Industry Rank	Sector Rank
ROA	-111.05%
ROE	N/A
ROIC	N/A

ROA(3y)-75.41%

ROA(5y)-63.18%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

With an excellent Gross Margin value of 102.73%, ALMDT belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.

In the last couple of years the Gross Margin of ALMDT has remained more or less at the same level.

ALMDT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	102.73%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y1.46%

GM growth 5Y0.99%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ALMDT does not have a ROIC to compare to the WACC, probably because it is not profitable.

ALMDT has about the same amout of shares outstanding than it did 1 year ago.

ALMDT has more shares outstanding than it did 5 years ago.

Compared to 1 year ago, ALMDT has a worse debt to assets ratio.

2.2 Solvency

ALMDT has an Altman-Z score of -11.86. This is a bad value and indicates that ALMDT is not financially healthy and even has some risk of bankruptcy.

Looking at the Altman-Z score, with a value of -11.86, ALMDT is doing worse than 72.73% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	-11.86

ROIC/WACCN/A

WACC7.5%

2.3 Liquidity

A Current Ratio of 0.36 indicates that ALMDT may have some problems paying its short term obligations.

With a Current ratio value of 0.36, ALMDT is not doing good in the industry: 81.82% of the companies in the same industry are doing better.

ALMDT has a Quick Ratio of 0.36. This is a bad value and indicates that ALMDT is not financially healthy enough and could expect problems in meeting its short term obligations.

The Quick ratio of ALMDT (0.36) is worse than 81.82% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.36
Quick Ratio	0.36

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 10.33% over the past year.

ALMDT shows a small growth in Revenue. In the last year, the Revenue has grown by 6.75%.

ALMDT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 20.72% yearly.

EPS 1Y (TTM)10.33%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%30.65%

Revenue 1Y (TTM)6.75%

Revenue growth 3Y3.75%

Revenue growth 5Y20.72%

Sales Q2Q%3.3%

3.2 Future

Based on estimates for the next years, ALMDT will show a very strong growth in Earnings Per Share. The EPS will grow by 26.15% on average per year.

The Revenue is expected to grow by 22.71% on average over the next years. This is a very strong growth

EPS Next Y46.62%

EPS Next 2Y30.92%

EPS Next 3Y26.15%

EPS Next 5YN/A

Revenue Next Year3.31%

Revenue Next 2Y17.55%

Revenue Next 3Y22.71%

Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALMDT. In the last year negative earnings were reported.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALMDT. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as ALMDT's earnings are expected to grow with 26.15% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y30.92%

EPS Next 3Y26.15%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for ALMDT!.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

MEDIAN TECHNOLOGIES

EPA:ALMDT (1/7/2026, 7:00:00 PM)

4.13

+0.23 (+5.9%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Technology

Earnings (Last)10-23 2025-10-23

Earnings (Next)04-27 2026-04-27/amc

Inst Owners10.84%

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap151.65M

Revenue(TTM)23.31M

Net Income(TTM)-22.21M

Analysts85.45

Price Target8.81 (113.32%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)-13.23%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)-78.63%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	6.51
P/FCF	N/A
P/OCF	N/A
P/B	N/A
P/tB	N/A
EV/EBITDA	N/A

EPS(TTM)-1.16

EYN/A

EPS(NY)-0.38

Fwd EYN/A

FCF(TTM)-0.4

FCFYN/A

OCF(TTM)-0.38

OCFYN/A

SpS0.63

BVpS-1.09

TBVpS-1.14

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-111.05%
ROE	N/A
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	102.73%
FCFM	N/A

ROA(3y)-75.41%

ROA(5y)-63.18%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y1.46%

GM growth 5Y0.99%

F-Score2

Asset Turnover1.17

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	36.41%
Cap/Sales	3.39%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	0.36
Quick Ratio	0.36
Altman-Z	-11.86

F-Score2

WACC7.5%

ROIC/WACCN/A

Cap/Depr(3y)101.99%

Cap/Depr(5y)84.13%

Cap/Sales(3y)5.46%

Cap/Sales(5y)4.27%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)10.33%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%30.65%

EPS Next Y46.62%

EPS Next 2Y30.92%

EPS Next 3Y26.15%

EPS Next 5YN/A

Revenue 1Y (TTM)6.75%

Revenue growth 3Y3.75%

Revenue growth 5Y20.72%

Sales Q2Q%3.3%

Revenue Next Year3.31%

Revenue Next 2Y17.55%

Revenue Next 3Y22.71%

Revenue Next 5YN/A

EBIT growth 1Y26.61%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year25.89%

EBIT Next 3Y24.38%

EBIT Next 5YN/A

FCF growth 1Y23.11%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y21.85%

OCF growth 3YN/A

OCF growth 5YN/A

MEDIAN TECHNOLOGIES / ALMDT.PA FAQ

What is the ChartMill fundamental rating of MEDIAN TECHNOLOGIES (ALMDT.PA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to ALMDT.PA.

What is the valuation status for ALMDT stock?

ChartMill assigns a valuation rating of 1 / 10 to MEDIAN TECHNOLOGIES (ALMDT.PA). This can be considered as Overvalued.

What is the profitability of ALMDT stock?

MEDIAN TECHNOLOGIES (ALMDT.PA) has a profitability rating of 1 / 10.

How financially healthy is MEDIAN TECHNOLOGIES?

The financial health rating of MEDIAN TECHNOLOGIES (ALMDT.PA) is 0 / 10.

MEDIAN TECHNOLOGIES (ALMDT.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

MEDIAN TECHNOLOGIES / ALMDT.PA FAQ

What is the ChartMill fundamental rating of MEDIAN TECHNOLOGIES (ALMDT.PA) stock?

What is the valuation status for ALMDT stock?

What is the profitability of ALMDT stock?

How financially healthy is MEDIAN TECHNOLOGIES?